Primary Open-angle Glaucoma
Showing NaN - NaN of 6
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Fayetteville, Arkansas
- +9 more
May 18, 2020
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Fayetteville, Arkansas
- +8 more
Mar 26, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Artesia, California
- +9 more
Feb 1, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Artesia, California
- +9 more
Mar 22, 2018
Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)
Completed
- Primary Open-angle Glaucoma
- Ocular Hypertension
- LX7101 (0.125%)
- +2 more
-
Morrow, Georgia
- +4 more
Aug 31, 2015